R1MD34 Stock Overview
Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ResMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$351.40 |
| 52 Week High | US$368.70 |
| 52 Week Low | US$187.67 |
| Beta | 0.69 |
| 11 Month Change | -4.66% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -4.45% |
| 5 Year Change | n/a |
| Change since IPO | 107.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| R1MD34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 4.6% | 0.9% | 0.9% |
| 1Y | n/a | 14.6% | -0.4% |
Return vs Industry: Insufficient data to determine how R1MD34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how R1MD34 performed against the BR Market.
Price Volatility
| R1MD34 volatility | |
|---|---|
| R1MD34 Average Weekly Movement | 9.2% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in BR Market | 8.1% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: R1MD34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine R1MD34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 9,980 | Mick Farrell | www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.
ResMed Inc. Fundamentals Summary
| R1MD34 fundamental statistics | |
|---|---|
| Market cap | R$207.69b |
| Earnings (TTM) | R$6.46b |
| Revenue (TTM) | R$27.91b |
32.1x
P/E Ratio7.4x
P/S RatioIs R1MD34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| R1MD34 income statement (TTM) | |
|---|---|
| Revenue | US$4.81b |
| Cost of Revenue | US$2.00b |
| Gross Profit | US$2.80b |
| Other Expenses | US$1.69b |
| Earnings | US$1.11b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.58 |
| Gross Margin | 58.33% |
| Net Profit Margin | 23.15% |
| Debt/Equity Ratio | 13.0% |
How did R1MD34 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield26%
Payout RatioDoes R1MD34 pay a reliable dividends?
See R1MD34 dividend history and benchmarks| ResMed dividend dates | |
|---|---|
| Ex Dividend Date | Nov 06 2024 |
| Dividend Pay Date | Dec 18 2024 |
| Days until Ex dividend | 19 days |
| Days until Dividend pay date | 23 days |
Does R1MD34 pay a reliable dividends?
See R1MD34 dividend history and benchmarks